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Clinical PerspectiveWhat Is New?Our analysis suggests the existence of a use rate to outcome effect for bilateral internal thoracic artery grafting.What Are the Clinical Implications?Our findings suggest the possibility that the creation of specialized tertiary centers for coronary surgery, similar to those that exist for aortic surgery and transplantation, may improve the outcomes of bilateral internal thoracic artery grafting.

Introduction {#jah33216-sec-0008}
============

The relationship between center or operator experience and outcome has extensively been described in medicine and in surgery.[1](#jah33216-bib-0001){ref-type="ref"} The volume/outcome (V/O) effect is particularly evident for technically complex procedures, such as off‐pump surgery or valve repair procedures.[2](#jah33216-bib-0002){ref-type="ref"} This has resulted in recommendations for minimum center‐ and surgeon‐specific procedural volumes, as well as for specialized referral centers for highly complex cardiovascular and cancer operations.[1](#jah33216-bib-0001){ref-type="ref"}

Coronary artery bypass grafting surgery (CABG) is the most common cardiac surgical procedure performed worldwide, and a V/O effect for CABG has been extensively described.[1](#jah33216-bib-0001){ref-type="ref"}, [3](#jah33216-bib-0003){ref-type="ref"}

The use of bilateral internal thoracic artery (BITA) increases the technical complexity of the CABG operation.[4](#jah33216-bib-0004){ref-type="ref"} Previously published studies on the V/O effect in CABG did not stratify the results according to the type of technique used, although in the great majority of the published series, BITA was used only in a small minority of patients.

We hypothesized that, because of the more complex nature of the procedure, a specific center experience to outcome relationship exists for BITA grafting; therefore, we aimed at investigating this by using a meta‐analytic approach.

Methods {#jah33216-sec-0009}
=======

We conducted this systematic review and meta‐analysis following the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses statement.[5](#jah33216-bib-0005){ref-type="ref"} Table [S1](#jah33216-sup-0001){ref-type="supplementary-material"} illustrates the Meta‐Analysis of Observational Studies in Epidemiology guidelines checklist. The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.

Search Strategy and Study Selection Criteria {#jah33216-sec-0010}
--------------------------------------------

OVID versions of MEDLINE and EMBASE were searched from January 1972 to June 2017 to identify all articles reporting the outcome of BITA in patients undergoing CABG.

The following keywords were used: "bilateral," "double," "mammary," "thoracic," "artery," "multiple," "total," "arterial," "revascularization," and "coronary." Their combinations were searched using the term "AND." All citations were screened for study inclusion independently by 2 investigators (A.D.F and M.G.). In case of disagreement, a consensus was reached. In addition, the bibliography of all studies and meta‐analyses was searched to identify further publications (backward snowballing).

Inclusion criteria for analysis were single‐institution study, sample size of at least 100 patients, and English language. We excluded studies in which the percentage of BITA use of the individual center (number of patients undergoing BITA/total number of patients undergoing CABG in the center in the study period=%BITA) could not be extracted. In case of overlapping between studies or multiple publications from the same center, only the publication with the largest sample size was included.

The critical appraisal of the quality of included studies was assessed using the Newcastle‐Ottawa Scale for observational studies.[6](#jah33216-bib-0006){ref-type="ref"} The highest possible score is 9 stars; \<6 stars was considered low quality, whereas ≥6 stars was considered high quality (Table [S2](#jah33216-sup-0001){ref-type="supplementary-material"}).

Data Abstraction {#jah33216-sec-0011}
----------------

The following data were abstracted: study period, country, institution, total sample size, number of patients undergoing BITA, %BITA, annual CABG volume of the individual center (total number of CABGs in the study/the study period), study design, and follow‐up duration. The following patient characteristics were abstracted: age, female sex, diabetes mellitus, left ventricular ejection fraction, number of grafts per patient, number of internal thoracic artery grafts per patient, use of internal thoracic artery sequentials, use of skeletonization technique for BITA harvesting, and chronic obstructive pulmonary disease.

For descriptive purposes, the studies were divided according to quartiles of %BITA (boundaries for the quartiles were 17.1%, 29.2%, and 50.3%; the range of %BITA was 3.7%--64%). In all the other analysis, %BITA was analyzed as a continuous variable.

For the BITA versus single internal thoracic artery (SITA) comparison, data were abstracted from the adjusted series only (covariate adjusted or propensity matched). Crude event rates, unadjusted and adjusted hazard ratios, 95% confidence intervals (CIs) for BITA and SITA, and log p‐rank values were abstracted. For the secondary outcomes, number of events was extracted for each outcome.

Continuous variables were expressed as median (25th--75th percentile) or as mean±SD. Categorical variables were reported as frequency (percentage).

Outcomes {#jah33216-sec-0012}
--------

The primary outcome was long‐term all‐cause mortality.

The secondary outcomes were operative mortality, perioperative myocardial infarction, perioperative stroke, deep sternal wound infections (DSWIs), and major postoperative adverse events, defined as the composite of operative mortality, perioperative myocardial infarction, perioperative stroke, and DSWIs. Major postoperative adverse event was derived only from studies that reported all 4 individual outcome components.

Analytic Plan and Statistical Analysis {#jah33216-sec-0013}
--------------------------------------

In the pooled analyses, the incident rate or the pooled event rates (PERs) of the primary and secondary outcomes in the BITA series were calculated according to the %BITA.

In the pairwise comparisons including only the adjusted studies, the relative risks of the primary and secondary outcomes in the BITA series were calculated according to the %BITA.

### Pooled analysis {#jah33216-sec-0014}

To account for the differential follow‐up times of the primary outcome in the various studies, an underlying Poisson process with a constant event rate was assumed with a total number of events observed within a treatment group of the total person‐time of follow‐up for that treatment group calculated from study follow‐up. A log‐link function was used to model the incidence rate (IR), and a random effect was used. When the number of events was not available from text or tables, the number of events was derived from the unadjusted Kaplan‐Meier curves using GetData Graph Digitizer software 2.26 (<http://getdata-graph-digitizer.com>) using a previously described method.[7](#jah33216-bib-0007){ref-type="ref"}

For secondary outcomes, the PERs with 95% CIs were calculated.

### BITA versus SITA comparison {#jah33216-sec-0015}

For the primary outcome, the generic inverse variance (DerSimonian‐Laird) method was used to pool the natural logarithm of the IR ratio across studies to account for potentially different follow‐up durations between the studies. We estimated the IR ratio through several means, depending on the available study data. When hazard ratios were provided, we took the natural logarithm of the hazard ratio; the standard error was derived from the 95% CI or log‐rank *P* value.[8](#jah33216-bib-0008){ref-type="ref"} When event rates were not readily available, they were extracted from Kaplan‐Meier curves.[7](#jah33216-bib-0007){ref-type="ref"}, [9](#jah33216-bib-0009){ref-type="ref"} The standard error was estimated from the number of events in each arm.[8](#jah33216-bib-0008){ref-type="ref"} For secondary outcomes, individual and pooled odds ratio (OR) with 95% CIs were used.

### Meta‐regression {#jah33216-sec-0016}

In the pooled and pairwise analysis, univariable meta‐regression was used to explore the association between %BITA and the primary and secondary outcomes.

A mixed‐effects meta‐regression model that contained both study‐specific covariates and random‐effect components was used to allow for the division of heterogeneity into an explained (by the covariates) and an unexplained (the random‐effects) component.[10](#jah33216-bib-0010){ref-type="ref"} Each study was weighted by the inverse of the variance of the estimate for that study, and between‐study variance was estimated with DerSimonian‐Laird estimator.

In both sets of analyses, a multivariable meta‐regression model was used to assess the association between %BITA with the primary outcome while also adjusting for age, sex, diabetes mellitus, and annual CABG hospital volume. A separate multivariable meta‐regression model, including %BITA, sex, diabetes mellitus, annual CABG volume, and skeletonization, was used to assess for the analysis of DSWI.

The Cochran Q statistic and the I^2^ test were used to assess studies' heterogeneity. For the primary outcome, if significant heterogeneity was detected (I^2^\>75%), a leave‐one‐out sensitivity analysis was performed to assess for single comparison driven inference. Funnel plots and Egger regression test were used to assess for potential publication bias. If publication bias was suspected, visual assessment of the cumulative forest plot and Duval and Tweedie\'s trim and fill methods were used for further assessment.

A random‐effect model (inverse variance method)[11](#jah33216-bib-0011){ref-type="ref"} was used for all the analysis. Hypothesis testing for equivalence was set at the 2‐tailed 0.05 level.

All analyses were performed using R, version 3.3.3 (R Project for Statistical Computing) using the following statistical packages: "meta" and "metafor"[12](#jah33216-bib-0012){ref-type="ref"}, [13](#jah33216-bib-0013){ref-type="ref"} within the RStudio, 0.99.489 (<http://www.rstudio.com>) and Comprehensive Meta‐Analysis V 3.0 (2006; Biostat, Inc, Englewood, NJ).

Results {#jah33216-sec-0017}
=======

Literature Search {#jah33216-sec-0018}
-----------------

The literature search identified 2899 potentially eligible studies. Twenty‐two additional articles were identified through backward snowballing. The Preferred Reporting Items for Systematic Reviews and Meta‐Analyses flow diagram is reported in Figure [1](#jah33216-fig-0001){ref-type="fig"}.

![Preferred Reporting Items for Systematic Reviews and Meta‐Analyses flow chart. BITA indicates bilateral internal thoracic artery; SITA, single internal thoracic artery.](JAH3-7-e009361-g001){#jah33216-fig-0001}

Studies' and Participants' Characteristics {#jah33216-sec-0019}
------------------------------------------

A total of 34 studies including 27 894 patients who had CABG using BITA were included.[14](#jah33216-bib-0014){ref-type="ref"}, [15](#jah33216-bib-0015){ref-type="ref"}, [16](#jah33216-bib-0016){ref-type="ref"}, [17](#jah33216-bib-0017){ref-type="ref"}, [18](#jah33216-bib-0018){ref-type="ref"}, [19](#jah33216-bib-0019){ref-type="ref"}, [20](#jah33216-bib-0020){ref-type="ref"}, [21](#jah33216-bib-0021){ref-type="ref"}, [22](#jah33216-bib-0022){ref-type="ref"}, [23](#jah33216-bib-0023){ref-type="ref"}, [24](#jah33216-bib-0024){ref-type="ref"}, [25](#jah33216-bib-0025){ref-type="ref"}, [26](#jah33216-bib-0026){ref-type="ref"}, [27](#jah33216-bib-0027){ref-type="ref"}, [28](#jah33216-bib-0028){ref-type="ref"}, [29](#jah33216-bib-0029){ref-type="ref"}, [30](#jah33216-bib-0030){ref-type="ref"}, [31](#jah33216-bib-0031){ref-type="ref"}, [32](#jah33216-bib-0032){ref-type="ref"}, [33](#jah33216-bib-0033){ref-type="ref"}, [34](#jah33216-bib-0034){ref-type="ref"}, [35](#jah33216-bib-0035){ref-type="ref"}, [36](#jah33216-bib-0036){ref-type="ref"}, [37](#jah33216-bib-0037){ref-type="ref"}, [38](#jah33216-bib-0038){ref-type="ref"}, [39](#jah33216-bib-0039){ref-type="ref"}, [40](#jah33216-bib-0040){ref-type="ref"}, [41](#jah33216-bib-0041){ref-type="ref"}, [42](#jah33216-bib-0042){ref-type="ref"}, [43](#jah33216-bib-0043){ref-type="ref"}, [44](#jah33216-bib-0044){ref-type="ref"}, [45](#jah33216-bib-0045){ref-type="ref"}, [46](#jah33216-bib-0046){ref-type="ref"}, [47](#jah33216-bib-0047){ref-type="ref"} Details of the individual studies are shown in Tables [1](#jah33216-tbl-0001){ref-type="table"} and [2](#jah33216-tbl-0002){ref-type="table"} and Table [S3](#jah33216-sup-0001){ref-type="supplementary-material"}. The weighted mean follow‐up time was 7.7±1.2 years. For the pairwise comparison, 27 adjusted studies (12 propensity matched) were included (75 334 patients; 19 290 BITAs and 56 044 SITAs). Eight studies (13 292 patients) were included in the analysis of the composite major postoperative adverse event.

###### 

Overview of the Included Studies: 1

  Study                                                       Year   Center                                                                                                                Study Period   Setting                                                                     Type of Study
  ----------------------------------------------------------- ------ --------------------------------------------------------------------------------------------------------------------- -------------- --------------------------------------------------------------------------- ---------------
  Benedetto et al[14](#jah33216-bib-0014){ref-type="ref"}     2014   Harefield Hospital (London, UK)                                                                                       2001--2013     First‐time isolated CABG                                                    Retrospective
  Buxton et al[15](#jah33216-bib-0015){ref-type="ref"}        1998   Austin and Repatriation Medical Center, University of Melbourne (Melbourne, Victoria, Australia)                      1985--1995     Isolated primary CABG                                                       Retrospective
  Calafiore et al[16](#jah33216-bib-0016){ref-type="ref"}     2004   University Hospital (Torino, Italy) and "G D\'Annunzio" University (Chieti, Italy)                                    1986--1999     Patients \<75 y who undergo first myocardial revascularization              Retrospective
  Carrier et al[17](#jah33216-bib-0017){ref-type="ref"}       2009   Montreal Heart Institute (Montreal, Quebec, Canada)                                                                   1995--2007     Isolated primary CABG                                                       Retrospective
  Danzer et al[18](#jah33216-bib-0018){ref-type="ref"}        2001   University Hospital (Geneva, Switzerland)                                                                             1983--1989     Isolated primary CABG                                                       Retrospective
  Dewar et al[19](#jah33216-bib-0019){ref-type="ref"}         1995   Vancouver Hospital and Health Sciences Centre, University of British Columbia (Vancouver, British Columbia, Canada)   1984--1992     Isolated primary CABG (93.2% were having a first operative procedure)       Retrospective
  Elmistekawy et al[20](#jah33216-bib-0020){ref-type="ref"}   2012   Ottawa Heart Institute (Ottawa, Ontario, Canada)                                                                      1997--2007     Isolated CABG in patients ≥65 y                                             Retrospective
  Endo et al[21](#jah33216-bib-0021){ref-type="ref"}          2001   Tokyo Women\'s Medical University (Tokyo, Japan)                                                                      1985--1998     Elective isolated primary CABG (including children with Kawasaki disease)   Retrospective
  Gansera et al[22](#jah33216-bib-0022){ref-type="ref"}       2001   Klinikum Bogenhausen (Munich, Germany)                                                                                1996--1999     Isolated CABG                                                               Retrospective
  Gansera et al[23](#jah33216-bib-0023){ref-type="ref"}       2004   Klinikum Bogenhausen (Munich, Germany)                                                                                1997--1999     Elective isolated primary CABG                                              Retrospective
  Grau et al[24](#jah33216-bib-0024){ref-type="ref"}          2015   The Valley Columbia Heart Center, Columbia University College of Physicians and Surgeons (Ridgewood, NJ)              1994--2013     Isolated CABG                                                               Retrospective
  Hirotani et al[25](#jah33216-bib-0025){ref-type="ref"}      2003   Tokyo Saiseikai Central Hospital (Minato‐Ku, Tokyo, Japan)                                                            1991--2003     Isolated primary CABG in diabetic patients                                  Retrospective
  Ioannidis et al[26](#jah33216-bib-0026){ref-type="ref"}     2001   St Luke\'s--Roosevelt Hospital Center (New York, NY)                                                                  1993--1996     Isolated CABG                                                               Prospective
  Itoh et al[27](#jah33216-bib-0027){ref-type="ref"}          2016   Saitama Medical Center, Jichi Medical University (Saitama, Japan)                                                     1990--2014     Isolated CABG in elderly patients (≥75 y)                                   Retrospective
  Johnson et al[28](#jah33216-bib-0028){ref-type="ref"}       1989   Milwaukee Heart Surgery Associates, SC, and St Mary\'s Hospital (Milwaukee, WI)                                       1972--1986     Isolated CABG (including redo)                                              Retrospective
  Jones et al[29](#jah33216-bib-0029){ref-type="ref"}         2000   Baylor College of Medicine and Veterans Affairs Medical Center (Houston, TX)                                          1986--1996     Isolated primary CABG in patients \>65 y                                    Retrospective
  Joo et al[30](#jah33216-bib-0030){ref-type="ref"}           2012   Yonsei Cardiovascular Hospital (Seoul, Republic of Korea)                                                             2000--2009     Isolated OPCAB                                                              Retrospective
  Kelly et al[31](#jah33216-bib-0031){ref-type="ref"}         2012   Queen Elizabeth II Health Sciences Center (Halifax, Nova Scotia, Canada)                                              1995--2009     Isolated primary CABG                                                       Retrospective
  Kinoshita et al[32](#jah33216-bib-0032){ref-type="ref"}     2015   Shiga University of Medical Science (Otsu, Japan)                                                                     2002--2014     Isolated CABG (patients stratified by GFR)                                  Retrospective
  Konstanty et al[33](#jah33216-bib-0033){ref-type="ref"}     2012   Collegium Medicum Jagiellonian University (Krakow, Poland)                                                            2006--2008     Isolated primary CABG in diabetic patients                                  Retrospective
  Kurlansky et al[34](#jah33216-bib-0034){ref-type="ref"}     2010   Florida Heart Research Institute (Miami, FL)                                                                          1972--1994     Isolated CABG                                                               Retrospective
  Locker et al[35](#jah33216-bib-0035){ref-type="ref"}        2012   Mayo Clinic (Rochester, MN)                                                                                           1993--2009     Isolated primary CABG                                                       Retrospective
  Lytle et al[36](#jah33216-bib-0036){ref-type="ref"}         2004   The Cleveland Clinic Foundation (Cleveland, OH)                                                                       1971--1989     Isolated primary CABG                                                       Retrospective
  Medalion et al[37](#jah33216-bib-0037){ref-type="ref"}      2015   Tel Aviv Sourasky Medical Center (Tel Aviv, Israel)                                                                   1996--2008     Isolated CABG in patients ≥70 y                                             Retrospective
  Mohammadi et al[38](#jah33216-bib-0038){ref-type="ref"}     2014   Quebec Heart and Lung Institute (Quebec City, Quebec, Canada)                                                         1991--2011     Isolated primary CABG in patients with EF ≤40%                              Retrospective
  Naunheim et al[39](#jah33216-bib-0039){ref-type="ref"}      1992   St Louis University Medical Center (St Louis, MO)                                                                     1972--1975     Isolated CABG                                                               Retrospective
  Navia et al[40](#jah33216-bib-0040){ref-type="ref"}         2016   Instituto Cardiovascular de Buenos Aires (Buenos Aires, Argentina)                                                    1996--2014     Isolated urgent or elective CABG (BITA grafting in a T configuration)       Retrospective
  Parsa et al[41](#jah33216-bib-0041){ref-type="ref"}         2013   Duke University Medical Center (Durham, NC)                                                                           1984--2009     Isolated CABG                                                               Prospective
  Pettinari et al[42](#jah33216-bib-0042){ref-type="ref"}     2014   Ziekenhuis Oost Limburg (Genk, Belgium) and University Hospitals Leuven (Leuven, Belgium)                             1972--2006     CABG in elderly patients (≥70 y)                                            Retrospective
  Pusca et al[43](#jah33216-bib-0043){ref-type="ref"}         2008   Emory University School of Medicine (Atlanta, GA)                                                                     1997--2006     Isolated CABG                                                               Retrospective
  Rosenblum et al[44](#jah33216-bib-0044){ref-type="ref"}     2016   Emory University School of Medicine (Atlanta, GA)                                                                     2003--2013     Primary isolated CABG                                                       Retrospective
  Stevens et al[45](#jah33216-bib-0045){ref-type="ref"}       2004   Montreal Heart Institute (Montreal, Quebec, Canada)                                                                   1985--1995     Isolated primary CABG with ≥3 grafts                                        Retrospective
  Tarelli et al[46](#jah33216-bib-0046){ref-type="ref"}       2001   Varese Hospital (Varese, Italy)                                                                                       1988--1990     Isolated CABG                                                               Retrospective
  Walkes et al[47](#jah33216-bib-0047){ref-type="ref"}        2002   Baylor College of Medicine and Veterans Affairs Medical center (Houston, TX)                                          1990--2000     Isolated CABG                                                               Retrospective

BITA indicates bilateral internal thoracic artery; CABG, coronary artery bypass grafting; EF, ejection fraction; GFR, glomerular filtration rate; OPCAB, off‐pump coronary artery bypass.

###### 

Overview of the Included Studies: 2

  Study                                                          Overall Population, n   BITA, n   Mean/Median Follow‐Up, y      Completeness of Follow‐Up, %
  -------------------------------------------------------------- ----------------------- --------- ----------------------------- ------------------------------
  Benedetto et al[14](#jah33216-bib-0014){ref-type="ref"}        4195                    750       4.8±3.2 (PSM sample)          100
  Buxton et al[15](#jah33216-bib-0015){ref-type="ref"}           2826                    1269      4.3                           95.9
  Calafiore et al[16](#jah33216-bib-0016){ref-type="ref"}        1602                    1026      BITA: 7.1±5.0                 100
  Carrier et al[17](#jah33216-bib-0017){ref-type="ref"}          6655                    1235      10                            99
  Danzer et al[18](#jah33216-bib-0018){ref-type="ref"}           521                     382       10                            97.5
  Dewar et al[19](#jah33216-bib-0019){ref-type="ref"}            1142                    377       4                             NR
  Elmistekawy et al[20](#jah33216-bib-0020){ref-type="ref"}      3940                    359       NR                            NR
  Endo et al[21](#jah33216-bib-0021){ref-type="ref"}             1131                    443       6.2                           99.3
  Gansera et al (2001)[22](#jah33216-bib-0022){ref-type="ref"}   3671                    1487      NR                            NR
  Gansera et al (2004)[23](#jah33216-bib-0023){ref-type="ref"}   1378                    716       5.3                           NR
  Grau et al[24](#jah33216-bib-0024){ref-type="ref"}             6666                    1544      BITA: 10.9±5                  100
  Hirotani et al[25](#jah33216-bib-0025){ref-type="ref"}         303                     179       NR                            95
  Ioannidis et al[26](#jah33216-bib-0026){ref-type="ref"}        1697                    867       NR                            NR
  Itoh et al[27](#jah33216-bib-0027){ref-type="ref"}             400                     107       9.0±5.8                       95.6
  Johnson et al[28](#jah33216-bib-0028){ref-type="ref"}          2014                    576       NR                            100
  Jones et al[29](#jah33216-bib-0029){ref-type="ref"}            510                     172       5.0±3.1                       100
  Joo et al[30](#jah33216-bib-0030){ref-type="ref"}              1749                    392       BITA: 6.9±2.1                 98.1
  Kelly et al[31](#jah33216-bib-0031){ref-type="ref"}            7633                    1079      BITA: 5.4                     NR
  Kinoshita et al[32](#jah33216-bib-0032){ref-type="ref"}        1203                    750       PSM BITA: 5.6±3.3             99
  Konstanty et al[33](#jah33216-bib-0033){ref-type="ref"}        147                     38        NR                            NR
  Kurlansky et al[34](#jah33216-bib-0034){ref-type="ref"}        4584                    2215      BITA: 12.7                    BITA: 96.7
  Locker et al[35](#jah33216-bib-0035){ref-type="ref"}           8295                    860       7.6±4.6                       100
  Lytle et al[36](#jah33216-bib-0036){ref-type="ref"}            10 124                  2001      BITA: 16.2±2.4                100
  Medalion et al[37](#jah33216-bib-0037){ref-type="ref"}         1627                    1045      8.2±4.5                       98
  Mohammadi et al[38](#jah33216-bib-0038){ref-type="ref"}        1795                    129       PSM BITA: 8.6±5.1             92.7
  Naunheim et al[39](#jah33216-bib-0039){ref-type="ref"}         365                     100       NR                            96.5
  Navia et al[40](#jah33216-bib-0040){ref-type="ref"}            2486                    2098      Median, 5.5 (IQR, 2.6--8.8)   95
  Parsa et al[41](#jah33216-bib-0041){ref-type="ref"}            17 609                  728       NR                            100
  Pettinari et al[42](#jah33216-bib-0042){ref-type="ref"}        3496                    1328      3.1                           100
  Pusca et al[43](#jah33216-bib-0043){ref-type="ref"}            10 811                  599       NR                            NR
  Rosenblum et al[44](#jah33216-bib-0044){ref-type="ref"}        8254                    873       Median, 2.8 (IQR, 1.1--4.9)   100
  Stevens et al[45](#jah33216-bib-0045){ref-type="ref"}          4382                    1835      BITA: 8±2                     98
  Tarelli et al[46](#jah33216-bib-0046){ref-type="ref"}          300                     150       BITA: 9.2±2.8                 100
  Walkes et al[47](#jah33216-bib-0047){ref-type="ref"}           1069                    158       NR                            NR

BITA indicates bilateral internal thoracic artery; IQR, interquartile range; NR, not reported; PSM, propensity score matched.

The included studies were published from 1989 to 2016, and the sample size ranged from 147 to 17 609.

### Primary outcome {#jah33216-sec-0020}

In the pooled analysis, the IR for long‐term mortality in the overall population was 2.83%/year (95% CI, 2.21%/year--3.61%/year; Table [3](#jah33216-tbl-0003){ref-type="table"}). The leave‐one‐out analysis is shown in Figure [S1](#jah33216-sup-0001){ref-type="supplementary-material"}, and the funnel plot and the cumulative analysis are shown in Figure [S2](#jah33216-sup-0001){ref-type="supplementary-material"}. %BITA was significantly and inversely associated with long‐term mortality in the univariable meta‐regression (β=−0.02, *P*=0.02; Figure [2](#jah33216-fig-0002){ref-type="fig"}A) and the multivariable meta‐regression (β=−0.03, *P*=0.04; Figure [2](#jah33216-fig-0002){ref-type="fig"}B).

###### 

Outcomes Summary

  Quartile                  No. of Studies   Patients   PER/IR, %   95% CI, %     Heterogeneity, I^2^, *P* Value   τ^2^
  ------------------------- ---------------- ---------- ----------- ------------- -------------------------------- -------
  Long‐term mortality                                                                                              
  First quartile            5                3377       3.68        2.18--6.21    98.40, *P*\<0.001                0.336
  Second quartile           8                4579       3.2         2.35--4.37    96.52, *P*\<0.001                0.185
  Third quartile            8                7712       4.45        2.73--7.26    99.40, *P*\<0.001                0.485
  Fourth quartile           7                3712       1.04        0.50--2.19    97.60, *P*\<0.001                0.924
  Overall                   28               19 380     2.83        2.21--3.61    98.90, *P*\<0.001                0.412
  Perioperative MI                                                                                                 
  First quartile            5                2598       1.2         0.49--2.91    78.972, *P*=0.001                0.778
  Second quartile           4                1530       2.121       1.02--4.36    60.970, *P*=0.053                0.329
  Third quartile            3                3954       2.454       0.97--6.08    93.294, *P*\<0.001               0.643
  Fourth quartile           6                5141       1.321       0.72--2.42    81.853, *P*\<0.001               0.432
  Overall                   18               2598       1.632       1.12--2.38    86.706, *P*\<0.001               0.546
  Stroke                                                                                                           
  First quartile            5                2598       1.045       0.64--1.70    27.658, *P*=237                  0.086
  Second quartile           6                2387       1.27        0.72--2.22    44.368, *P*=110                  0.208
  Third quartile            4                4846       1.101       0.84--1.44    0.000, *P*=0.530                 0
  Fourth quartile           7                5891       1.426       0.75--2.70    87.346, *P*\<0.001               0.636
  Overall                   22               15 722     1.142       0.93--1.40    74.605, *P*\<0.001               0.36
  DSWI                                                                                                             
  First quartile            5                3197       2.805       2.17--3.61    0.000, *P*=0.551                 0
  Second quartile           3                2387       3.304       1.38--7.72    39.075, *P*=0.194                0.5
  Third quartile            5                8981       1.525       1.18--1.97    30.744, *P*=0.217                0.164
  Fourth quartile           5                6037       1.675       1.28--2.19    0.000, *P*=0.735                 0
  Overall                   18               20 602     1.968       1.70--2.28    46.688, *P*=0.016                0.281
  Perioperative mortality                                                                                          
  First quartile            3                2385       1.328       0.45--3.87    88.184, *P*\<0.001               0.822
  Second quartile           6                3158       1.562       0.65--3.72    82.822, *P*\<0.001               0.877
  Third quartile            5                5398       1.442       0.89--2.32    74.551, *P*=0.003                0.213
  Fourth quartile           5                4845       1.923       1.10--3.34    84.795, *P*\<0.001               0.342
  Overall                   19               15 786     1.591       1.15--2.19    80.805, *P*\<0.001               0.352
  MAE                                                                                                              
  First quartile            2                1232       7.725       3.30--17.03   93.918, *P*\<0.001               0.393
  Second quartile           2                966        7.122       1.44--28.62   91.912, *P*\<0.001               1.314
  Third quartile            2                1739       5.474       4.50--6.65    0.000, *P*=0.498                 0
  Fourth quartile           3                3525       6.632       3.67--11.70   94.552, *P*\<0.001               0.282
  Overall                   9                7462       5.682       4.74--6.79    89.869, *P*\<0.001               0.204

IR was used for long‐term mortality. CI indicates confidence interval; DSWI, deep sternal wound infection; IR, incidence rate; MAE, major postoperative adverse event (operative mortality+MI+stroke+DSWI); MI, myocardial infarction; PER, pooled event rate.

![The effect of the percentage of bilateral internal thoracic artery (BITA) use on the long‐term mortality (expressed as incidence rate) according to the univariable (A) and multivariable (B) meta‐regressions. DM indicates diabetes mellitus; totCABG, total coronary artery bypass grafting.](JAH3-7-e009361-g002){#jah33216-fig-0002}

In the pairwise comparison with SITA, the use of BITA was associated with a significantly lower long‐term mortality (IR ratio, 0.78; 95% CI, 0.72--0.84; Figure [S3](#jah33216-sup-0001){ref-type="supplementary-material"}). %BITA was significantly and inversely associated with the IR ratio for long‐term mortality in both the univariable meta‐regression (β=−0.006, *P*=0.01; Figure [3](#jah33216-fig-0003){ref-type="fig"}A) and the multivariable meta‐regression (β=−0.008, *P*=0.03; Figure [3](#jah33216-fig-0003){ref-type="fig"}B).

![The effect of the percentage of bilateral internal thoracic artery (BITA) use on the long‐term mortality (expressed as incident rate ratio) according to the univariable (A) and multivariable (B) meta‐regressions. CABG indicates coronary artery bypass grafting; DM, diabetes mellitus.](JAH3-7-e009361-g003){#jah33216-fig-0003}

### Secondary outcomes {#jah33216-sec-0021}

In the pooled analysis, the PER for operative mortality was 1.6% (95% CI, 1.2%--2.2%), the PER for myocardial infarction was 1.6% (95% CI, 1.1%--2.4%), the PER for perioperative stroke was 1.1% (95% CI, 0.9%--1.4%), the PER for DSWI was 2.2% (95% CI, 1.7%--2.7%), and the PER for major postoperative adverse event was 5.7% (95% CI, 4.7%--6.8%) (Table [3](#jah33216-tbl-0003){ref-type="table"}). %BITA was significantly and inversely associated with DSWI, according to the univariable and multivariable meta‐regressions (β=−0.001 \[*P*=0.006\] and β=−0.02 \[*P*\<0.001\], respectively; Table [3](#jah33216-tbl-0003){ref-type="table"} and Figure [4](#jah33216-fig-0004){ref-type="fig"}). %BITA did not influence the other secondary outcomes (Table [3](#jah33216-tbl-0003){ref-type="table"} and Figure [S4](#jah33216-sup-0001){ref-type="supplementary-material"}).

![The effect of the percentage of bilateral internal thoracic artery (BITA) use on the pooled event rate of deep sternal wound infection by univariable (A) and multivariable (B) meta‐regressions. CABG indicates coronary artery bypass grafting; DM, diabetes mellitus.](JAH3-7-e009361-g004){#jah33216-fig-0004}

In the pairwise comparison with SITA, BITA use was associated with a significantly higher incidence of DSWI (OR, 1.58; 95% CI, 1.15--2.19) and a significantly lower rate of perioperative stroke (OR, 0.76; 95% CI, 0.61--0.94). %BITA was significantly and inversely associated with the OR for DSWI by univariable and multivariable meta‐regressions (β=−0.020 \[*P*=0.02\] and β=−0.03 \[*P*=0.005\], respectively; Figure [5](#jah33216-fig-0005){ref-type="fig"}).

![The effect of the percentage of bilateral internal thoracic artery (BITA) use on the odds ratio of deep sternal wound infection by univariable (A) and multivariable (B) meta‐regressions. CABG indicates coronary artery bypass grafting; DM, diabetes mellitus.](JAH3-7-e009361-g005){#jah33216-fig-0005}

No significant differences were found for the other secondary outcomes (Figure [S5](#jah33216-sup-0001){ref-type="supplementary-material"}).

Discussion {#jah33216-sec-0022}
==========

An inverse relationship between hospital volume and clinical outcome has been described extensively in surgery.[1](#jah33216-bib-0001){ref-type="ref"} Some data suggest that the V/O relationship can be more evident for more complex procedures, such as off‐pump CABG, or higher‐risk patients.[2](#jah33216-bib-0002){ref-type="ref"}

The V/O effect in CABG has been the focus of a large amount of research. Despite controversy related to the methodological quality of the sources used in the published studies and the lack of a clear‐cut explanation, it is usually accepted that hospitals that perform a high annual volume of CABG and have more experience with the procedure have better outcomes than hospitals that perform a smaller number of procedures.[1](#jah33216-bib-0001){ref-type="ref"}, [2](#jah33216-bib-0002){ref-type="ref"}, [3](#jah33216-bib-0003){ref-type="ref"} The use of BITA during CABG adds technical complexity to the operation. In a survey of all UK consultant cardiac surgeons, the perceived increased technical difficulty and need of a learning curve were the most frequent reason to explain the low adoption rate of BITA.[4](#jah33216-bib-0004){ref-type="ref"}

In the recently published ART (Arterial Revascularization Trial), only 83.6% of the patients randomized to BITA received the assigned treatment (versus 96.1% in the conventional CABG group).[48](#jah33216-bib-0048){ref-type="ref"} This high crossover rate in the BITA series is a testament to higher technical complexity of the operation, and it is even more meaningful if one considers that only expert BITA surgeons were allowed to participate in ART. However, it also raises the possibility that the BITA surgeons were not all equally experienced in BITA grafting because the crossover rate varied from 0% to 42.9% on a center level and from 0% to 100% for the 168 participating surgeons, suggesting the need for appropriate and documented experience for participation in trials involving complex technical procedures. Thus, as complexity of the coronary surgery increases with the addition of a BITA grafting strategy, institution experience with BITA may play an ever‐increasing role on outcomes. However, to date, this subject has not been investigated in detail.

Our data suggest that a relationship between the rate of BITA use at the center level and the clinical results exists at least for the 2 most important outcomes associated with BITA grafting: long‐term survival and incidence of DSWI. In our analysis, long‐term mortality was significantly and inversely associated with %BITA, with better survival reported by centers with high %BITA. In the pairwise comparison with SITA, the long‐term survival benefit associated with the use of BITA was significantly associated with %BITA, with centers with high %BITA reporting a significantly larger survival advantage for patients undergoing BITA. The effect of %BITA on long‐term mortality remained significant even when entering the annual hospital volume as a covariate in the meta‐regression model, suggesting the existence of an "experience effect" specific for BITA grafting and independent from the V/O relationship for standard CABG.

The rate of DSWI and the increase in the risk of DSWI in the BITA group were also significantly and inversely associated with %BITA. Centers with high %BITA reported a lower incidence of DSWI in the BITA series and a lower relative risk of DSWI in the BITA group compared with the SITA series. Furthermore, the incidence and risk of the short‐term outcomes, such as operative mortality, perioperative myocardial infarction, and perioperative stroke, were not influenced by the %BITA.

Taken together, our findings seem to suggest that the reasons for the reported difference in outcomes between centers at high and low %BITA are not strictly technical, because outcomes that are heavily influenced by technical factors, such as perioperative myocardial infarction, stroke, and operative mortality, were not significantly associated with %BITA. One explanation for our results may be better patient selection and grafting strategy in centers at high %BITA. It is possible that more experienced centers were more proficient in selecting appropriate patients who would benefit from BITA grafting and the use of the arterial grafts.

It is notable that 67% of the studies in the highest quartile of %BITA versus 38% in the lowest quartile used BITA sequentials (*P*=0.03). It has been shown that an increase in the number of BITA anastomoses is associated with better clinical outcome.[49](#jah33216-bib-0049){ref-type="ref"}

For DSWI, the adoption of the skeletonized technique for harvesting was similar between high and low BITA users (42.9% in the first quartile and 57.1% in the fourth quartile; *P*=0.56), and the association between the OR for DSWI and %BITA was confirmed, even in the multivariable meta‐regression model after adjusting for skeletonization. These results suggest that BITA skeletonization alone is not the explanation for the reported difference in DWSI.

This analysis must be interpreted in the context of some limitations. We used %BITA as opposed to BITA volume as a marker of experience with BITA because we believe that the rate of use is a stronger surrogate measure of familiarity, comfort, and skill in the operation than the absolute volume of procedures performed. However, this assumption is based on the authors' opinion, and has never been objectively validated. We did not capture individual surgeon\'s experience, which may be more important than center\'s experience. Also, the included studies used different surgical protocols and definition of outcomes and were in different stages of their BITA learning curve, leading to heterogeneity in the analyzed data. Most important, an unavoidable publication bias exists, because all centers were in some way experienced in the use of BITA (although at different levels). Our analysis probably does not capture the results of inexperienced centers or beginners in BITA grafting who are unlikely to publish their results. In addition, meta‐regressions can only be used to assess association and do not infer causality. Nonetheless, despite these limitations, the reproducibility of our results, on the basis of multiple different statistical approaches, supports the robustness of our reported findings.

In conclusion, our analysis suggests the existence of a use rate to outcome effect for BITA grafting. In our study, centers that used BITA more frequently reported a reduced risk of sternal complications and achieved better long‐term survival compared with SITA. Our findings suggest the possibility that the creation of specialized tertiary centers for coronary surgery, similar to those that exist for aortic surgery and transplantation, may improve the outcomes of BITA grafting.
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